Do probiotics reduce the risk of Clostridioides difficile infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Do Probiotics Reduce Risk of C. Diff?

Yes, probiotics can reduce the risk of C. difficile infection, but only specific strains should be used, primarily in high-risk hospitalized patients receiving antibiotics, and they should be started within 2 days of antibiotic initiation.

Recommended Probiotic Strains

The 2020 AGA guidelines provide a conditional recommendation for using specific probiotic strains in adults and children on antibiotic treatment 1:

  • Saccharomyces boulardii (RR 0.41; 95% CI 0.22-0.79)
  • 2-strain combination: L. acidophilus CL1285 + L. casei LBC80R (RR 0.22; 95% CI 0.11-0.42)
  • 3-strain combination: L. acidophilus + L. delbrueckii subsp bulgaricus + B. bifidum (RR 0.35; 95% CI 0.15-0.85)
  • 4-strain combination: L. acidophilus + L. delbrueckii subsp bulgaricus + B. bifidum + S. salivarius subsp thermophilus (RR 0.28; 95% CI 0.11-0.67)

Do not use L. rhamnosus ATCC 53103 - this strain showed increased recurrence of CDI (RR 2.63) 1.

Who Benefits Most

The benefit is risk-stratified and most pronounced in patients with:

  • High baseline CDI risk (>15%) - typically hospitalized inpatients on broad-spectrum antibiotics 1
  • Overall pooled data shows 60% relative risk reduction (RR 0.40; 95% CI 0.30-0.52) across 39 trials with 9,955 patients 1
  • Recent 2025 Cochrane review confirms 50% relative risk reduction (RR 0.50; 95% CI 0.38-0.64) with absolute risk reduction of 1.6% 2

Patients with low baseline risk (<2%) - mainly outpatients in the community - showed no significant benefit 1.

Critical Timing Factor

Start probiotics within 2 days of antibiotic initiation for maximum efficacy. Meta-regression analysis demonstrates that efficacy decreases with each day of delay (p=0.04) 3:

  • Started ≤2 days: RR 0.32 (95% CI 0.22-0.48)
  • Started >2 days: RR 0.70 (95% CI 0.40-1.23)

This represents a clinically meaningful difference - early administration reduces CDI risk by 68% versus only 30% with delayed administration.

Important Caveats and Contraindications

Who should NOT receive probiotics:

  • Severely immunocompromised patients 1
  • Critically ill patients 2
  • Patients who place high value on avoiding costs and have low CDI risk 1

The 2018 IDSA/SHEA guidelines state there are insufficient data to recommend probiotics for primary CDI prevention outside clinical trials 4, reflecting a more conservative stance than the AGA. This divergence exists because the IDSA/SHEA guidelines prioritize the heterogeneity and methodological limitations in the evidence base.

Quality of Evidence

The evidence quality is low to moderate due to:

  • High heterogeneity in study populations, probiotic strains, and dosing
  • Unclear or high risk of bias in most trials
  • Potential publication bias (many registered trials never published) 1
  • Industry funding in 28 of 47 studies 2

However, the 2025 Cochrane review upgraded the overall certainty to high quality for the primary outcome, with results robust to sensitivity analyses 2.

Safety Profile

Probiotics are probably safe with likely fewer adverse events than placebo (RR 0.86; 95% CI 0.72-1.01; moderate-certainty evidence) 2. Common side effects in both groups include abdominal cramping, nausea, flatulence, and soft stools - no significant difference between probiotic and control groups.

Practical Algorithm

For hospitalized patients starting antibiotics:

  1. Assess baseline CDI risk (>15% = high risk: elderly, multiple antibiotics, recent hospitalization)
  2. If high risk + not immunocompromised → Start one of the four recommended probiotic formulations within 2 days of antibiotic initiation
  3. If low risk (<2%) or outpatient → Probiotics not recommended
  4. Continue probiotics throughout antibiotic course

Number needed to treat: 65 - for every 65 patients treated with probiotics, one case of CDI is prevented 2.

The most recent high-quality evidence (2025 Cochrane review with 15,260 participants) supports a small but meaningful absolute benefit in appropriate patient populations 2, while acknowledging that strain-specific effects and optimal dosing require further investigation.

References

Related Questions

In a patient on cefuroxime who is taking Saccharomyces boulardii probiotic and yogurt, should she continue the probiotic as a preventive measure for Clostridioides difficile infection?
How do I suspect Clostridioides difficile-associated diarrhea (CDAD) and what is the appropriate management for antibiotic-associated diarrhea?
In an initial episode of Clostridioides difficile-associated diarrhea, after stopping the inciting antimicrobial if possible, what is the appropriate treatment?
Does omeprazole increase the risk of Clostridioides difficile infection?
In an 85-year-old nursing home resident with chronic diarrhea and a negative Clostridioides difficile test, what bulk‑forming agent should be used to treat the stool?
What are the clinical and physical B‑cell–related manifestations in a patient with chronic lymphocytic leukemia?
Is the American College of Obstetricians and Gynecologists (ACOG) Committee Opinion 280 triage criteria still used for adnexal lesion assessment?
What is the appropriate evaluation and management for a 50-year-old male with iron overload affecting the liver and spine?
Why would a woman in her 30s have a low total testosterone level of approximately 3 ng/dL?
How does the accumulation of adenosine during wakefulness signal its breakdown?
How should I evaluate and manage a patient with isolated elevated bilirubin and otherwise normal laboratory tests?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.